Literature DB >> 8659101

Mutation of vaccinia virus gene G2R causes suppression of gene A18R ts mutants: implications for control of transcription.

R C Condit1, Y Xiang, J I Lewis.   

Abstract

This report provides genetic evidence that two vaccinia virus genes, A18R and G2R, both of which affect the fidelity of viral transcription in vivo, interact with each other or act on a common biochemical pathway. Previous experiments with the antipoxviral drug isatin-beta-thiosemicarbazone suggest that lethal mutation of gene G2R would compensate for mutations in gene A18R. We therefore tested the hypothesis that gene G2R is an extragenic suppressor of A18R mutations. First, we constructed a recombinant which contains both a G2R deletion mutation and an A18R temperature-sensitive mutation and found that this recombinant was viable. Second, we isolated both cold-sensitive and temperature-insensitive phenotypic revertants of A18R temperature-sensitive mutants and found in both cases that the revertants contained G2R mutations. In the case of the cold-sensitive revertants, we were able to prove that the cold-sensitive phenotype mapped to the G2R gene. Combined with the biochemical data on A18R and G2R, these results imply that the A18R and G2R genes interact with each other either directly or indirectly in a fashion which affects the fidelity of intermediate and late viral transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8659101     DOI: 10.1006/viro.1996.0280

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Authors:  Y Xiang; D A Simpson; J Spiegel; A Zhou; R H Silverman; R C Condit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

2.  A new vaccinia virus intermediate transcription factor.

Authors:  P Sanz; B Moss
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  A cellular protein binds vaccinia virus late promoters and activates transcription in vitro.

Authors:  M Zhu; T Moore; S S Broyles
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Genetic Confirmation that the H5 Protein Is Required for Vaccinia Virus DNA Replication.

Authors:  Kathleen A Boyle; Matthew D Greseth; Paula Traktman
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

5.  A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription.

Authors:  Steven G Cresawn; Richard C Condit
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

Review 6.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

7.  The genome of fowlpox virus.

Authors:  C L Afonso; E R Tulman; Z Lu; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Identification of Vaccinia Virus Replisome and Transcriptome Proteins by Isolation of Proteins on Nascent DNA Coupled with Mass Spectrometry.

Authors:  Tatiana G Senkevich; George C Katsafanas; Andrea Weisberg; Lisa R Olano; Bernard Moss
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

9.  Nucleoside Triphosphate Phosphohydrolase I (NPH I) Functions as a 5' to 3' Translocase in Transcription Termination of Vaccinia Early Genes.

Authors:  Ryan Hindman; Paul Gollnick
Journal:  J Biol Chem       Date:  2016-05-06       Impact factor: 5.157

10.  MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination.

Authors:  S T Tang; M Wang; K Lamberth; M Harndahl; M H Dziegiel; M H Claesson; S Buus; O Lund
Journal:  Arch Virol       Date:  2008-09-12       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.